I will now conduct a review of your current portfolio and provide recommendations based on the market conditions.

Given the limited information available on the market data, I suggest focusing on your existing positions and potential adjustments to maximize returns.

### Recommendations:

1. **ATYR (aTyr Pharma, Inc.):**
   - **Hold:** Given the lack of current price data, it is advisable to hold onto your 5 shares of ATYR for now.

2. **BETR (Betterware de Mexico, S.A.B. de C.V.):**
   - **Hold:** Similar to ATYR, with no current price data, it is best to maintain your 1 share of BETR.

3. **CCLD (Celedor, Ltd.):**
   - **Hold:** Keep holding your 25 shares of CCLD until more market data becomes available.

4. **CSBR (Champions Oncology, Inc.):**
   - **Hold:** Hold onto your 3 shares of CSBR at this time.

5. **Cash Balance:**
   - **Hold:** With a cash balance of $7.43, it is advisable to keep it available for any future opportunities or adjustments.

### Summary:
Given the current lack of market data, I recommend maintaining your existing positions and observing the market for any potential changes. It is crucial to monitor the stocks closely and be prepared to make adjustments as more information becomes available. Remember, the goal is to generate maximum returns within the specified timeframe.